• English
  • Sign In
  • Contact Us
Catalog Products » Recombined SARS-CoV2 Spike stable cell line

CHO-K1/Spike Stable Cell Line

Description SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that cause severe respiratory illness. SARS-CoV-2 Spike Protein is derived from 2019-nCoV, which is composed of a S1 domain and S2 domain. The S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. It is believed that SARS-CoV-2 Spike Protein (RBD) has potential value for the diagnosis of the virus.
To further study the Spike protein of SARS-CoV-2, GenScript developed and successfully established a stable cell line, which can stably overexpress the Spike protein of SARS-CoV-2.
Species SARS-CoV-2
Culture Medium F-12K, 10% FBS, 8 μg/ml Puromycin
Freeze Medium 95% complete growth medium, 5% DMSO
QC Mycoplasma negative

Stability 20 passages
Storage Liquid nitrogen immediately upon receiving

In Vitro binding assay or used as immunogen

  • CHO-K1/Spike Stable Cell Line
  • CHO-K1/Spike Stable Cell Line

    Flow cytometry analysis of Spike protein expression in CHO-K1/Spike cells via binding with ACE2 protein.

Notice there is no results found, you can visit "Citations Database" for other results.

For more documents, please visit "Technical Support".

Cat. No. M00803
Size Price
2 vials Quote

20% off your first order! Offer valid till December 31st, 2020.